The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)
Abstract
Background — Leptin plays a role in fat metabolism and correlates with insulin resistance and other markers of the metabolic syndrome, independent of total adiposity. Therefore, we hypothesized that raised leptin levels may identify men at increased risk of a coronary event in the West of Scotland Coronary Prevention Study (WOSCOPS). Methods and Results — Plasma leptin levels were measured at baseline in 377 men (cases) who subsequently experienced a coronary event and in 783 men (controls) who remained free of an event during the 5-year follow-up period of the study. Controls were matched to cases on the basis of age and smoking history and were representative of the entire WOSCOPS cohort. Leptin levels were significantly higher in cases than controls (5.87±2.04 ng/mL versus 5.04±2.09 ng/mL, P <0.001). In univariate analysis, for each 1 SD increase in leptin, the relative risk (RR) of an event increased by 1.25 (95% confidence interval [CI], 1.10 to 1.43; P <0.001). There was minimal change in this RR with correction for body mass index (RR, 1.24; 95% CI, 1.06 to 1.45; P =0.006) or with further correction for classic risk factors, including age, lipids, and systolic blood pressure (RR, 1.20; 95% CI, 1.02 to 1.42; P =0.03). Leptin correlated with C-reactive protein ( r =0.24, P <0.001) and, even with this variable added to the model, leptin retained significance as a predictor of coronary events (RR, 1.18; 95% CI, 1.00 to 1.39; P =0.05) at the expense of C-reactive protein. Conclusions — We show, for the first time, in a large prospective study that leptin is a novel, independent risk factor for coronary heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Adipose tissue as an endocrine and paracrine organ
Mohamed-Ali, V, Pinkney, J., & Coppack, S. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800770 · Cited by 999
Leptin: The Tale of an Obesity Gene
Caro, J. F., Sinha, M. K., Kolaczynski, J. W., Li Zhang, P., & Considine, R. V. (1996) · Diabetes · doi:10.2337/diab.45.11.1455 · Cited by 982
Freeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844
Self-citationLipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease
Packard, C. J., O'Reilly, D. S. J., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431603 · Cited by 823
Self-citationAcute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro
Kolaczynski, J. W., Nyce, M. R., Considine, R. V., Boden, G., Nolan, J. J., Henry, R., Mudaliar, S. R., Olefsky, J., & Caro, J. F. (1996) · Diabetes · doi:10.2337/diab.45.5.699 · Cited by 700
Relationship Between Insulin Sensitivity and Plasma Leptin Concentration in Lean and Obese Men
Segal, K. R., Landt, M., & Klein, S. (1996) · Diabetes · doi:10.2337/diab.45.7.988 · Cited by 493
Insulin and Cortisol Promote Leptin Production in Cultured Human Fat Cells
Wabitsch, M., Bo Jensen, P., Blum, W. F., Christoffersen, C. T., Englaro, P., Heinze, E., Rascher, W., Teller, W., Tornqvist, H., & Hauner, H. (1996) · Diabetes · doi:10.2337/diab.45.10.1435 · Cited by 472
Plasma Leptin and Insulin Relationships in Obese and Nonobese Humans
Dagogo-Jack, S., Fanelli, C., Paramore, D., Brothers, J., & Landt, M. (1996) · Diabetes · doi:10.2337/diab.45.5.695 · Cited by 396
Leptin is associated with increased risk of myocardial infarction
Söderberg, S., Ahrén, B., Jansson, J. ‐., Johnson, O., Hallmans, G., Asplund, K., & Olsson, T. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00571.x · Cited by 356
McNeely, M. J., Boyko, E. J., Weigle, D. S., Shofer, J. B., Chessler, S. D., Leonnetti, D. L., & Fujimoto, W. Y. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.65 · Cited by 308
CLELAND, S. J., SATTAR, N., PETRIE, J. R., FOROUHI, N. G., ELLIOTT, H. L., & CONNELL, J. M. C. (2000) · Clinical Science · doi:10.1042/cs0980531 · Cited by 249
Self-citationZIMMET, P., BOYKO, E. J., COLLIER, G. R., & de COURTEN, M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07783.x · Cited by 236
Rumley, A., Norrie, J., Ford, I., Shepherd, J., Cobbe, S., Macfarlane, P., Packard, C., Lowe, G., & The West of Scotland Coronary Prevention Study Group (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614066 · Cited by 208
Self-citationEffect of long-term changes in diet and exercise on plasma leptin concentrations
Reseland, J. E., Anderssen, S. A., Solvoll, K., Hjermann, I., Urdal, P., Holme, I., & Drevon, C. A. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.240 · Cited by 205
Leptin Is a Risk Marker for First-Ever Hemorrhagic Stroke in a Population-Based Cohort
Söderberg, S., Ahrén, B., Stegmayr, B., Johnson, O., Wiklund, P.-G., Weinehall, L., Hallmans, G., & Olsson, T. (1999) · Stroke · doi:10.1161/01.str.30.2.328 · Cited by 179
D Fareed on behalf of Mauritius NCD Study Group, Zimmet, P., Collins, V. R., de Courten, M., Hodge, A. M., Collier, G., Gk, D., Alberti, K., Tuomilehto, J. O., Hemraj, F., et al. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800559 · Cited by 126
McConway, M. G., Johnson, D., Kelly, A., Griffin, D., Smith, J. L., & Wallace, E. M. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001899771 · Cited by 124
Self-citationCouillard, C., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., Lupien, P.-J., & Després, J. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.782 · Cited by 111
Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women
Söderberg, S., Olsson, T., Eliasson, M., Johnson, O., & Åhrén, B. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00472.x · Cited by 103
Increased Plasma Leptin Levels Are Associated With Fat Accumulation in Japanese Americans
Chessler, S. D., Fujimoto, W. Y., Shofer, J. B., Boyko, E. J., & Weigle, D. S. (1998) · Diabetes · doi:10.2337/diab.47.2.239 · Cited by 96
Is Leptin Concentration Associated with the Insulin Resistance Syndrome in Nondiabetic Men?
Haffner, S. M., Mykkänen, L., Rainwater, D. L., Karhapää, P., & Laakso, M. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00698.x · Cited by 53
THE CO-ORDINATED CYTOKINE/HORMONE RESPONSE TO ACUTE INJURY INCORPORATES LEPTIN
Wallace, A. M., Sattar, N. A., & McMillan, D. C. (2000) · Cytokine · doi:10.1006/cyto.2000.0674 · Cited by 52
Self-citationReducing the burden of diabetes: managing cardiovascular disease
KEEN, H., Clark, C. M., & Laakso, M. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199905/06)15:3<186::aid-dmrr30>3.0.co;2-5 · Cited by 43
Haffner, S., Miettinen, H., Mykkänen, L., & Stern, M. P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800679 · Cited by 30
Gaw, A., Brown, E. A., Docherty, G., & Ford, I. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00259-2 · Cited by 13
Self-citation
Cited by
Chait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529
Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease
Shamsuzzaman, A. S. M., Gersh, B. J., & Somers, V. K. (2003) · JAMA · doi:10.1001/jama.290.14.1906 · Cited by 1,188
Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
Bastien, M., Poirier, P., Lemieux, I., & Després, J.-P. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.10.016 · Cited by 1,125
Metabolic syndrome: pathophysiology, management, and modulation by natural compounds
Rochlani, Y., Pothineni, N. V., Kovelamudi, S., & Mehta, J. L. (2017) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944717711379 · Cited by 1,097
Wisse, B. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141966.69934.21 · Cited by 933
Metadata
- Authors
- Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N.
- Venue
- Circulation
- Published
- 2001-12-17
- Volume
- 104
- Issue
- 25
- Pages
- 3052-3056
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2141600407
- Cited by
- 825
- References
- 27
- FWCI
- 21.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.